We then co-cultured wild-type or mutant 293T cells with TALL-104 cells, a CD8+ T cell line that is MHC non-restricted tumor-lytic, particularly for glioma [42,43,44,45]. The gene discussed is CD8A; the disease is central nervous system cancer.